Abstract
Hyocholic acid (HCA) and its derivatives are found in trace amounts in human blood but constitute approximately 76% of the bile acid (BA) pool in pigs, a species known for its exceptional resistance to type 2 diabetes. Here, we show that BA depletion in pigs suppressed secretion of glucagon-like peptide-1 (GLP-1) and increased blood glucose levels. HCA administration in diabetic mouse models improved serum fasting GLP-1 secretion and glucose homeostasis to a greater extent than tauroursodeoxycholic acid. HCA upregulated GLP-1 production and secretion in enteroendocrine cells via simultaneously activating G-protein-coupled BA receptor, TGR5, and inhibiting farnesoid X receptor (FXR), a unique mechanism that is not found in other BA species. We verified the findings in TGR5 knockout, intestinal FXR activation, and GLP-1 receptor inhibition mouse models. Finally, we confirmed in a clinical cohort, that lower serum concentrations of HCA species were associated with diabetes and closely related to glycemic markers.
Original language | English |
---|---|
Pages (from-to) | 791-803.E7 |
Number of pages | 20 |
Journal | Cell Metabolism |
Volume | 33 |
Issue number | 4 |
Early online date | 17 Dec 2020 |
DOIs | |
Publication status | Published - 6 Apr 2021 |
Scopus Subject Areas
- Physiology
- Molecular Biology
- Cell Biology
User-Defined Keywords
- bile acid
- diabetes
- FXR
- glucagon-like peptide-1
- glucose homeostasis
- hyocholic acid
- hyodeoxycholic acid
- insulin
- pig
- TGR5